Acute Complications of Hemodialysis and their Prevention and Treatment

  • Salim K. Mujais
  • Todd Ing
  • Carl Kjellstrand


Hemodialysis is the most successful and most commonly used form of organ replacement therapy. Its success and widespread worldwide use attest to its safety. The latter is based on a combination of factors primordial among which is the vigilance and attention to detail of healthcare workers providing the therapy. Advances in dialysis technology (both machinery and disposables) contribute significantly to the safety of this therapeutic modality. Awareness of the potential complications of the procedure should facilitate preventive and remedial interventions. The present chapter offers a discussion of the most common complications and their therapies


Dialysis Patient Hemodialysis Patient Continuous Ambulatory Peritoneal Dialysis Artif Organ Nephrol Dial Transplant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Degoulet P, Roulx J-P, Aime F: Programme dialyse-informatique III. Données epidemiologiques stratégies de dialyse et resultats biologiques. J Urol Nephrol (Paris) 82: 1001, 1976Google Scholar
  2. 2.
    Rosa AA, Fryd DS, Kjellstrand CM: Dialysis symptoms and stabilization in long-term dialysis. Practical application of the cusum plot. Arch Intern Med 140: 804, 1980PubMedGoogle Scholar
  3. 3.
    Orofino L, Marcen R, Quereda C, Villafruela J, Sabater J, Matesanz R, Pascual J, Ortuno J: Epidemiology of symptomatic hypotension in hemodialysis: is cool dialysate beneficial for all patients? Am J Nephrol 10: 177, 1990PubMedGoogle Scholar
  4. 4.
    Capuano A, Sepe V, Cianfrone P, Castellano T, Andreucci VE: Cardiovascular impairment, dialysis strategy and tolerance in elderly and young patients on maintenance haemodialysis. Nephrol Dial Transplant 5: 1023, 1990PubMedGoogle Scholar
  5. 5.
    Jost CM, Agarwal R, Khair, Grayburn PA, Victor RG, Henrich WL: Effects of cooler temperature dialysate on hemodynamic stability in ‘problem’ dialysis patients. Kidney Int 44: 606, 1993PubMedGoogle Scholar
  6. 6.
    Anonymous: Acute intradialytic well-being: results of a clinical trial comparing polysulfone with cuprophan. Bergamo Collaborative dialysis Study Group. Kidney Int 40: 714, 1991Google Scholar
  7. 7.
    Shinzato T, Nakai S, Odani H, Nakane K, Takai I, Maeda K: Relationship between dialysis induced hypotension and adenosine released by ischemic tissue. ASAIO J 38: 286, 1992Google Scholar
  8. 8.
    Shinzato T, Milwa M, Nakai S, Morita H, Odani H, Inove I, Maeda K: Role of adenosine in dialysis-induced hypotension. Am Soc Nephrol 4: 1987, 1994Google Scholar
  9. 9.
    Santoro A, Mancini E, Spongano M, Rossi M, Paolini F, Zucchelli P: A haemodynamic study of hypotension during haemodialysis using electrical bioimpedance cardiography. Nephrol Dial Transplant (Suppl 1): 147, 1990Google Scholar
  10. 10.
    de Vries PJ, Kouw PM, vander Meer N, Olthof CG, Oe LP, Donker AJ, de Vries PM: Non-invasive monitoring of blood volume during hemodialysis: its relation with post-dialytic dry weight. Kidney Int 44: 851, 1993PubMedGoogle Scholar
  11. 11.
    Sherman RA, Torres F, Cody RP: The effect of red cell transfusion on hemodialysis-related hypotension. Am J Kidney Dis 11: 33, 1988PubMedGoogle Scholar
  12. 12.
    Lins LE, Hedenborg G, Jacobson SH et al.: Blood pressure reduction during hemodialysis correlates to intradialytic changes in plasma volume. Clin Nephrol 37: 308, 1992PubMedGoogle Scholar
  13. 13.
    Schneditz D, Roob J, Oswald M, Pogglitsch H, Moser M, Kenner T, Binswager U: Nature and rate of vascular refilling during hemodialysis and ultrafiltration. Kidney Int 42: 1425, 1992PubMedGoogle Scholar
  14. 14.
    Di Maggio A, Basile C, Scatizzi A: Plasma volume changes induced by sequential ultrafiltration-hemodialysis and sequential hemodialysis-ultrafiltration. Int J Artif Organs 10: 291, 1987PubMedGoogle Scholar
  15. 15.
    Bauer JH, Brooks CS: Body fluid composition in chronic renal failure. Clin Nephrol 16: 114, 1981PubMedGoogle Scholar
  16. 16.
    Van SJ, Bauer J, Carey J: The effect of dialysate sodium concentration on body fluid compartment volume, plasma renin activity and plasma aldosterone concentration in chronic hemodialysis patients. Am J Kidney Dis 2: 58, 1982Google Scholar
  17. 17.
    Fauchald P: Transcapillary colloid osmotic gradient and body fluid volumes in renal failure. Kidney Int 29: 895, 1986PubMedGoogle Scholar
  18. 18.
    Fleming SJ, Wilkinson JS, Greenwood RN, Aldridge C, Baker LR, Cattell WR: Effect of dialysate composition on intercompartmental fluid shift. Kidney Int 32: 267, 1987PubMedGoogle Scholar
  19. 19.
    Kimura G, Van SJ, Bauer JH: Model prediction of plasma volume change induced by hemodialysis. J Lab Clin Med 104: 932, 1984PubMedGoogle Scholar
  20. 20.
    Martin MA, Perez R, Gomez J, Burdiel LG, Andres E, Castillo D, Moreno E, Aljama P: Sequential hypertonic dialysis. Nephron 40: 458, 1985Google Scholar
  21. 21.
    Po CL, Afolabi M, Raja RM: The role of sequential ultrafiltration and varying dialysate sodium on vascular stability during hemodialysis. ASAIO J 39: 798, 1993Google Scholar
  22. 22.
    Swartz RD, Somermeyer MG, Hsu CH: Preservation of plasma volume during hemodialysis depends on dialysate osmolality. Am J Nephrol 2: 189, 1982PubMedCrossRefGoogle Scholar
  23. 23.
    Basile C, Coates JE, Ulan RA: Plasma volume changes induced by hypertonic hemodiafiltration and standard hemodialysis. Am J Nephrol 7: 264, 1987PubMedGoogle Scholar
  24. 24.
    Hsu CH, Swartz RD, Somermeyer MG, Raj A: Bicarbonate hemodialysis: influence on plasma refilling and hemodynamic stability. Nephron 38: 202, 1984PubMedGoogle Scholar
  25. 25.
    Maeda K, Morita H, Shinzato T, Vega BV, Kobayakawa H, Ishihara T, Inagaki H, Igarashi I, Kitano T: Role of hypovolemia in dialysis-induced hypotension. Artif Organs 12: 116, 1988PubMedGoogle Scholar
  26. 26.
    Hampl H, Paeprer H, Unger V, Kessel MW: Hemodynamics during hemodialysis, sequential ultrafiltration and hemofiltration. J Dial 3: 51, 1979PubMedGoogle Scholar
  27. 27.
    Nakamura Y, Ikeda T, Takata S, Yokoi H, Hlrono M, Abe T, Takazakura E, Kobayashi K: The role of peripheral capacitance and resistance vessels in hypotension following hemodialysis. Am Heart J 121: 1170, 1991PubMedGoogle Scholar
  28. 28.
    Maeda K, Fujita Y, Shinzato T, Morita H, Kobayakawa H, Takai I: Mechanism of dialysis-induced hypotension. Trans Am Soc Artif Intern Organs 35: 245, 1989Google Scholar
  29. 29.
    Bradley JR, Evans DB, Gore SM, Cowley AJ: Is dialysis hypotension caused by an abnormality of venous tone? [published erratum appears in Br Med J (Clin Res Ed) 297: 330, 1988]. Br Med J 296: 1634, 1988Google Scholar
  30. 30.
    Bradley JR, Evans DB, Cowley AJ: Comparison of vascular tone during combined haemodialysis with ultrafiltration and during ultrafiltration followed by haemodialysis: a possible mechanism for dialysis hypotension. Br Med J 300: 1312, 1990Google Scholar
  31. 31.
    Kooman JP, Gladziwa U, Bocker G, van BL, van HJ, Leunissen KM: Role of the venous system in hemodynamics during ultrafiltration and bicarbonate dialysis. Kidney Int 42: 718, 1992PubMedGoogle Scholar
  32. 32.
    Rozich JD, Smith B, Thomas JD, Zile MR, Kaiser J, Mann DL: Dialysis-induced alterations in left ventricular filling: mechanisms and clinical significance. Am J Kidney Dis 17: 277, 1991PubMedGoogle Scholar
  33. 33.
    Converse RJ, Jacobsen TN, Jost CM, Toto RD, Grayburn PA, Obregon TM, Fouad-Tarazi F, Victor RG: Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest 90: 1657, 1992PubMedGoogle Scholar
  34. 34.
    Agarwal A, Anand IS, Sakhuja V, Chugh KS: Effect of dialysis and renal transplantation on autonomic dysfunction in chronic renal failure. Kidney Int 40: 489, 1991PubMedGoogle Scholar
  35. 35.
    Heber ME, Lahiri A, Thompson D, Raftery EB: Baroreceptor, not left ventricular, dysfunction is the cause of hemodialysis hypotension. Clin Nephrol 32: 79, 1989PubMedGoogle Scholar
  36. 36.
    Lilley JJ, Golden J, Stone RA: Adrenergic regulation of blood pressure in chronic renal failure. J Clin Invest 57: 1190, 1976PubMedGoogle Scholar
  37. 37.
    McGrath BP, Tiller DJ, Bune A, Chalmers JP, Korner PI, Uther JB: Autonomie blockade and the Valsalva maneuver in patients on maintenance hemodialysis: a hemodynamic study. Kidney Int 12: 294, 1977PubMedGoogle Scholar
  38. 38.
    Hakim RM, Pontzer MA, Tilton D, Lazarus JM, Gottlieb MN: Effects of acetate and bicarbonate dialysate in stable chronic dialysis patients. Kidney Int 28: 535, 1985PubMedGoogle Scholar
  39. 39.
    Diamond SM, Henrich WL: Acetate dialysate versus bicarbonate dialysate: a continuing controversy. (Review) Am J Kidney Dis 9: 3, 1987PubMedGoogle Scholar
  40. 40.
    Malberti F, Sudan M, Colussi G, Minetti L: The influence of dialysis fluid composition on dialysis tolerance. Nephrol Dial Transplant 2: 93, 1987PubMedGoogle Scholar
  41. 41.
    DiBello V, Bianchi AM, Caputo MT et al.: Fractional shortening/end-systolic stress correlation in the evaluation of left ventricular contractility in patiends treated by acetate dialysis and lactate haemofiltration. Nephrol Dial Transplant (Suppl 1): 115, 1990Google Scholar
  42. 42.
    Wizemann V, Soetanto R, Thormann J, Lubbecke F, Kramer W: Effects of acetate on left ventricular function in hemodialysis patients. Nephrol 64: 101, 1993Google Scholar
  43. 43.
    Daugirdas JT: Dialysis hypotension: a hemodynamic analysis. Kidney Int 39: 233, 1991PubMedGoogle Scholar
  44. 44.
    Sherman RA, Bialy GB, Gazinski B, Bernholc AS, Eisinger RP: The effect of dialysate calcium levels on blood pressure during hemodialysis. Am J Kidney Dis 8: 244, 1986PubMedGoogle Scholar
  45. 45.
    Kjellstrand CM: Vasodilatory hormones in hemodialysis. Int J Artif Organs 13, 1990Google Scholar
  46. 46.
    Odar CI, Kjellstrand CM, Theodorsson E: Is calcitonin gene-related peptide (CGRP) a regulator of blood pressure in hemodialysis patients? Int J Artif Organs 13: 134, 1990Google Scholar
  47. 47.
    Hegbrant J, Martensson L, Thysell H, Ekman R, Boberg U: Effects of sham hemodialysis on plasma levels of vasoactive peptides in patients wtih uremia. ASAIO J 38: 197, 1992Google Scholar
  48. 48.
    Hegbrant J, Thysell H, Martensson L, Ekman R, Boberg U: Changes in plasma levels of vasoactive peptides during sequential bicarbonate hemodialysis. Nephron 63: 309, 1993PubMedGoogle Scholar
  49. 49.
    Hegbrant J, Thysell H, Martensson L, Ekman R, Boberg U: Changes in plasma levels of vasoactive peptides during standard bicarbonate hemodialysis. Nephron 63: 303, 1993PubMedGoogle Scholar
  50. 50.
    Niwa T, Fujishiro T, Uema K et al.: Effect of hemodialysis on plasma levels of vasoactive peptides: endothelin, calcitonin gene-related peptide and human atrial natriuretic peptide. Nephron 64: 552, 1993PubMedCrossRefGoogle Scholar
  51. 51.
    Sturani A, Degli EE, Chiarini C, Spongano M, Santoro A, Zucchelli P: Failure of naloxone in reversal hemodialysis-induced hypotension. Blood Purif 3: 184, 1985PubMedGoogle Scholar
  52. 52.
    Sherman RA, Torres F, Cody RP: Postprandial blood pressure changes during hemodialysis. Am J Kidney Dis 12: 37, 1988PubMedGoogle Scholar
  53. 53.
    Barakat MM, Nawab ZM, Yu AW, Lau AH, Ing TS, Daugirdas JT: Hemodynamic effects of intradialytic food ingestion and the effects of caffeine. Am Soc Nephrol 3: 1813, 1993Google Scholar
  54. 54.
    DeFremont JF, Coevert B, Andrejak M, Makdassi R, Quichaud J, Lambrey G, Gueris J, Caillens C, Harichaux P, Alexandre JM, Fournier A: Effects of antihypertensive drugs on dialysis-resistant hypertension, plasma renin and dopamine betahydroxylase activities, metabolic risk factors and calcium phosphate homeostasis. Comparison of metoprolol, alphamethyldopa and clonidine in a crossover trial. Clin Nephrol 12: 198, 1979Google Scholar
  55. 55.
    Sadowski RH, Allred EN, Jabs K: Sodium modeling ameliorate intradialytic and interdialytic symptoms in young hemodialysis patients. Am Soc Nephrol 4: 1192, 1993Google Scholar
  56. 56.
    Zawada ET, Bennett EP, Steinson JB, Ramirez G: Serum calcium in blood pressure regulation during hemodialysis. Arch Intern Med 141: 657, 1981PubMedGoogle Scholar
  57. 57.
    Maynar J, Cruz C, Kleerekope RM, Levin N: Blood pressure response to changes in serum ionized calcium during hemodialysis. Ann Intern Med 104: 358, 1986Google Scholar
  58. 58.
    Pierides AM, Kurts SB, Johnson W: Ultrafiltration followed by hemodialysis. A longterm trial and acute studies. J Dial 2: 325, 1978PubMedGoogle Scholar
  59. 59.
    Jones EO, Ward MK, Hoenich NA, Kerr DN: Separation of dialysis and ultrafiltration — does it really help? Proc Eur Dial Transplant Assoc 14: 160, 1977PubMedGoogle Scholar
  60. 60.
    Maggiore Q, Pizzarelli F, Zoccali C, Sisca S, Nicolo F: Influence of blood temperature on vascular stability during hemodialysis and isolated ultrafiltration. Int J Artif Organs 8: 175, 1985PubMedGoogle Scholar
  61. 61.
    Quereda C, Marcen R, Lamas S et al.: Hemodialysis associated hypotension and dialysate temperature. Life Support Systems 1: 18, 1985Google Scholar
  62. 62.
    Sherman RA, Rubin MP, Cody RP, Eisinger RP: Amelioration of hemodialysis-associated hypotension by the use of cool dialysate. Am J Kidney Dis 5: 124, 1985PubMedGoogle Scholar
  63. 63.
    Kerr PG, van BC, Dawborn JK: Assessment of the symptomatic benefit of cool dialysate. Nephron 52: 166, 1989PubMedGoogle Scholar
  64. 64.
    Marcen R, Quereda C, Orofino L et al.: Hemodialysis with low-temperature dialysate: a long-term experience. Nephron 49: 29, 1988PubMedGoogle Scholar
  65. 65.
    Stiller S, Wirtz D, Waterbar F, Gladziwa U, Dakshinamurty KV, Mann H: Less symptomatic hypotension using blood volume controlled ultrafiltration. Trans Am Soc Artif Intern Organs 37: 138, 1991Google Scholar
  66. 66.
    Sturniolo A, Costanzi S, Barbera G, Ruffini MP, Passalacqua S, Fulignati P, Splendiani G: Computerised monitoring of sodium and fluid during haemodialysis. Nephrol Dial Transplant 1: 162, 1990Google Scholar
  67. 67.
    Skroeder NR, Jacobson SH, Lins K, Kjellstrand CM: Biocompatibility of dialysis membranes is of no importance for objective or subjective symptoms during or after hemodialysis. Trans Am Soc Artif Intern Organs 36: M637, 1990Google Scholar
  68. 68.
    Anonymous, Bergamo Collaborative Dialysis Study Group: Acute intradialytic well-being: results of a clinical trial comparing polysulfone with cuprophan. Kidney Int 40: 714, 1991Google Scholar
  69. 69.
    Branger B, Deschodt G, Oules R, Balducchi JP, Granolleras C, Aisabadani B, Fourcade J, Shaldon S: Biocompatible membranes and hemodynamic tolerance to hemodialysis. Kidney Int 24: S196, 1988Google Scholar
  70. 70.
    Collins DM, Lambert MB, Tannenbaum JS, Oliverio M, Schwab SJ: Tolerance of hemodialysis: a randomized prospective tiral of high-flux versus conventional high-efficiency hemodialysis. Am Soc Nephrol 4: 148, 1993Google Scholar
  71. 71.
    Ahmad S, Robertson HT, Golper TA et al.: Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int 38: 912, 1990PubMedGoogle Scholar
  72. 72.
    Iida N, Tscubakihara Y, Shirai D, Imada A, Suzuki M: Treatment of dialysis-induced hypotension with L-threo-3, 4-dihydroxyphenylserine. Nephrol Dial Transplant 9: 1130, 1994PubMedGoogle Scholar
  73. 73.
    Borges HF, Kjellstrand CM: On the effect of prostaglandin inhibition on the clinical course of chronic hemodialysis. Nephron 42: 120, 1986PubMedGoogle Scholar
  74. 74.
    Gong R, Lindberg J, Abrarns J, Whitaker WR, Wade CE, Gouge S: Comparison of hypertonic saline solutions and dextran in dialysis-induced hypotension. Am Soc Nephrol 3: 1808, 1993Google Scholar
  75. 75.
    Stejskalova A, Stejskal J, Elleder M: Iatrogenic generalized storage of dextran in patients on regular dialysis. Czech Med 10: 201, 1987PubMedGoogle Scholar
  76. 76.
    Bergonzi G, Paties C, Vassallo G, Zangrandi A, Poisetti PG, Ballochi S, Fontana F, Scarpioni L: Dextran deposits in tissues of patients undergoing haemodialysis. Nephrol Dial Transplant 5: 54, 1990PubMedGoogle Scholar
  77. 77.
    Warren SE, Olshan A, Beck CHJ: Use of phenylephrine HCI for treatment of refractory dialysis-aggravated hypotension. Nephrol Dial Transplant 9: 492, 1980Google Scholar
  78. 78.
    Shimoyama H, Suwata J, Saitoh H, Oguchi K, Kobayashi S, Kawada Y: Changes in catecholamine level in hypotensive patients subjected to dialysis. Nipon Jinzo Gakkai Shi 31: 165, 1989Google Scholar
  79. 79.
    Lindberg JS, Copley JB, Melton K, Wade CE, Abrams J, Goode D: Lysine vasopressin in the treatment of refractory hemodialysis-induced hypotension. Am J Nephrol 10: 269, 1990PubMedCrossRefGoogle Scholar
  80. 80.
    Flynn JJ, Mitchell MC, Caruso FS, McElligott MA: A pilot evaluation of midodrine to treat patients with hemodialysis hypotension. (Abstract) Am Soc Nephrol 4: 345, 1993Google Scholar
  81. 81.
    De Broe M, DeBacker W: Pathophysiology of hemodialysis-associated hypoxemia. (Review) Adv Nephrol Necker Hosp 18: L297, 1989Google Scholar
  82. 82.
    Ozdemir O, Arik N, Ozcebe O, Arinsoy T, Sungur C, Dundar S, Turgan C, Yasauul U, Caglar S, Kiragli S: Evidence for the role of dialysis hypoxemia in the pathogenesis of hemodialysis-induced rise in tissue-type plasminogen activator. Thromb Res 67: 697, 1992PubMedGoogle Scholar
  83. 83.
    Pitcher WD, Diamond SM, Henrich WL: Pulmonary gas exchange during dialysis in patients with obstructive lung disease. Chest 96: 1136, 1989PubMedGoogle Scholar
  84. 84.
    Cardoso M, Vinay P, Vinet B, Léveillé M, Prud’homme M, Téjédor A, Courteau M, Gougoux A, St. Louis G, Lapierre L, Piette Y: Hypoxemia during hemodialysis: a critical review of the facts. (Review) Am J Kidney Dis 11: 281, 1988PubMedGoogle Scholar
  85. 85.
    Gilli Y, Binswanger U: Continuous pulse-oxymetry during haemodialysis. Nephron 44: 368, 1990Google Scholar
  86. 86.
    Fujiwara Y, Hagihara B, Yamauchi A, Shirai D: Hypoxemia and hemodialysis-induced symptomatic hypotension. Clin Nephrol 24: 9, 1985PubMedGoogle Scholar
  87. 87.
    Francos GC, Besarab A, Burke F, Peters J, Tahamont MV, Gee MH, Flynn JT, Gzesh D: Dialysis-induced hypoxemia: membrane dependent and membrane independent causes. Am J Kidney Dis 5: 191, 1985PubMedGoogle Scholar
  88. 88.
    Ganss R, Aarseth HP, Nordby G: Prevention of hemodialysis associated hypoxemia by use of low-concentration bicarbonate dialysate. ASAIO J 38: 820, 1992PubMedGoogle Scholar
  89. 89.
    Germain MJ, Burke EJ, Braden GL, Fitzgivvons JP: Amelioration of hemodialysis-induced fall in PaO2 with exercise. Am J Nephrol 5: 351, 1985PubMedGoogle Scholar
  90. 90.
    Igarashi H, Kioi S, Gejyo F, Arakawa M: Physiologic approach to dialysis-induced hypoxemia. Effects of dialyzer material and dialysate composition. Nephron 41: 62, 1985PubMedGoogle Scholar
  91. 91.
    Jones JG, Bembridge JL, Sapsford DJ, Turney JH: Continuous measurements os oxygen saturation during haemodialysis. Nephrol Dial Transplant 7: 110, 1992PubMedGoogle Scholar
  92. 92.
    Kishimoto T, Tanaka H, Maekawa M, Ivanovich P, Levin N, Bergstrom J, Klinkmann H: Dialysis-induced hypoxaemia. Nephrol Dial Transplant 2: 25, 1993Google Scholar
  93. 93.
    Oh MS, Uribarri J, Del Monte ML, Heneghan WF, Kee CS, Friedman EA, Carroll H: A mechanism of hypoxemia during hemodialysis. Consumption of CO2 in metabolism of acetata. Am J Nephrol 5: 366, 1985PubMedGoogle Scholar
  94. 94.
    Ross EA, Tashkin D, Chenoweth D, Webber MM, Nissenson AR: Pulmonary leukosequestration without hypoxemia during hemodialysis. Int J Artif Organs 10: 367, 1987PubMedGoogle Scholar
  95. 95.
    Soliani F, Davoli V, Franco V, Lindner G, Lusanti T, Parisoli A, Brini M, Borgatti PP: Intradialytic changes of the oxyhaemoglobin dissociation curve during acetate and bicarbonate haemodialysis. Possible interactions with haemodialysis-associated hypoxaemia. Nephrol Dial Transplant 1: 119, 1990Google Scholar
  96. 96.
    Wiegmann TB, MacDougall ML, Diederich DA: Dialysis leukopenia, hypoxemia, and anaphylatoxin formation: effect of membrane, bath, and citrate anticoagulation. AmJ Kidney Dis 11: 418, 1988Google Scholar
  97. 97.
    Gawaz M, Mujais SK, Schmidt B, Gurland HJ: Plateletleukocyte aggregation during hemodialysis. Kidney Int 46: 489, 1994PubMedGoogle Scholar
  98. 98.
    Chou CT, Wasserstein A, Schumacher HJ, Fernandez P: Musculoskeletal manifestations in hemodialysis patients. J Rheumatol 12: 1149, 1985PubMedGoogle Scholar
  99. 99.
    McGee SR: Muscle cramps. Arch Intern Med 150: 511, 1990PubMedGoogle Scholar
  100. 100.
    Piergies AA, Atkinson AJ, Hubler GL, Del GF: Activation of renin-angiotensin system does not cause skeletal muscle cramps during hemodialysis. Int Journal Clin Pharmacol Ther Toxicol 28: 405, 1990Google Scholar
  101. 101.
    Kaplan B, Wang T, Rammohan M, Del GF, Molteni A, Atkinson AJ: Response to head-up tilt in cramping and noncramping hemodialysis patients. Int J Clin Pharmacol Ther Toxicol 30: 173, 1992PubMedGoogle Scholar
  102. 102.
    Cryer PE, Silverberg AB, Santiago JV, Shan SD: Plasma catecholamines in diabetes. The syndrome of hypoadrenergic and hyperadrenergic postural hypotension. Am J Med 64: 407, 1978PubMedGoogle Scholar
  103. 103.
    Sidhom O, Odeh Y, Krumlovsky F, Budris WA, Wamg Z, Pospisil PA, Atkinson AJ Jr: Low-dose prazosin in patients with muscle cramps during hemodialysis. Clin Pharmacol Ther 56: 445, 1994PubMedCrossRefGoogle Scholar
  104. 104.
    Barrett BJ, Vavasour HM, Major A, Parfrey PS: Clinical and psychological correlates of somatic symptoms in patients on dialysis. Nephron 55: 10, 1990PubMedGoogle Scholar
  105. 105.
    Hemando P, Caramelo C, Lopez GD, Hernando L: Muscle cramps: a cause of elevated creatine kinase levels in hemodialysis patient [see comments]. Nephron 55: 231, 1990Google Scholar
  106. 106.
    Canzanello VJ, Hylander RB, Sands RE, Morgan TM, Jordan J, Burkart JM: Comparison of 50% dextrose water. 25% mannitor, and 23.5% saline for the treatment of hemo-dialysis-associated muscle cramps. Trans Am Soc Artif Intern Organs 37: 649, 1991Google Scholar
  107. 107.
    Roca AO, Jarjoura D, Blend D, Cugino A, Rutecki GW, Nuchikat PS, Whittier FC: Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO J 38: 481, 1992Google Scholar
  108. 108.
    Sever MS, Kocak N: Chloroquine phosphate reduces the frequency of muscle cramps during maintenance hemodialysis. (Letter) Nephron 56, 1990Google Scholar
  109. 109.
    Popli S, Ing TS, Daugirdas JT, Kheirbek AO, Viol GW, Vilbar RM, Gandhi VC: Severe reactions to cuprophan capillary dialyzers. Artif Organs 6: 312, 1982PubMedCrossRefGoogle Scholar
  110. 110.
    Ing TS, Daugirdas JT, Popli S, Gandhi VC: First-use syndrome with cuprammonium cellulose dialyzers. Int J Artif Organs 6: 235, 1983PubMedGoogle Scholar
  111. 111.
    Nicholls A: Ethylene oxide and anaphylaxis during haemodialysis. Br Med J 292: 1221, 1986Google Scholar
  112. 112.
    Daugirdas JT, Ing TS, Roxe DM, Ivanovich PT, Krumlovsky F, Popli S, McLaughlin MM: Severe anaphylactoid reactions to cuprammonium cellulose hemodialyzers. Arch Intern Med 145: 489, 1985PubMedGoogle Scholar
  113. 113.
    Daugirdas JT, Ing TS: First-use reactions during hemodialysis: a definition of subtypes. Kidney Int 33(Suppl 24): 537, 1988Google Scholar
  114. 114.
    Rockel A, Thiel C, Abdelhamid S, Fiegel P, Walb D: Three cases of hemodialysis-associated hypersensitivity reactions. Int J Artif Organs 8: 179, 1985PubMedGoogle Scholar
  115. 115.
    Villarroel F, Ciarkowski AA: A survey on hypersensitivity reactions in hemodialysis. Artif Organs 9:231, 1985PubMedGoogle Scholar
  116. 116.
    Caruana RJ: First-use reactions: a potential hazard for referral centers. Int J Artif Organs 12: 688, 1989PubMedGoogle Scholar
  117. 117.
    Cavaillon JM, Poignet JL, Fitting C, Delons S, David B: Reduction of allergice reactions in patients undergoing long-term hemodialysis. J Allergy Clin Immunol 92: 355, 1993PubMedGoogle Scholar
  118. 118.
    Grammer LC, Harris KE, Shaughnessy MA, Dolovich J, Patterson R, Evans S: Antibodies to toluene diisocyanate in patients with and without dialysis anaphylaxis. Artif Organs 15: 2, 1991PubMedCrossRefGoogle Scholar
  119. 119.
    Lemke HD, Heidland A, Schaefer RM: Hypersensitivity reactions during haemodialysis: role of complement fragments and ethylene oxide antibodies. Nephrol Dial Transplant 5: 264, 1990PubMedGoogle Scholar
  120. 120.
    Levin NW, Zasuwa G: Relationship between dialyzer type and signs and symptoms. Nephrol Dial Transplant 8(Suppl 2): 30, 1993PubMedGoogle Scholar
  121. 121.
    Masin G, Polenakovic M, Ivanovski N, Atanasov N, Olivera S, Cakalaroski K: Hypersensitivity reactions to ethylene oxide: clinical experience. Nephrol Dial Transplant 3: 50, 1991Google Scholar
  122. 122.
    Tielemans C, Goldman M, Vanherweghem JL: Immediate hypersensitivity reactions and hemodialysis. (Review) Adv Nephrol Necker Hosp 22: 401, 1993PubMedGoogle Scholar
  123. 123.
    Walter J, Taraba I: Dialysis hypersensitivity. Nephrol Dial Transplant 3: 47, 1991Google Scholar
  124. 124.
    Lemke HD: Mediation of hypersensitivity reactions during hemodialysis by IgE antibodies against ethylene oxide. Artif Organs 11: 104, 1987PubMedGoogle Scholar
  125. 125.
    Windebank AJ, Blexrud MD: Residual ethylene oxide in hollow fiber hemodialysis units is neurotoxic in vitro. Ann Neuro 26: 63, 1989Google Scholar
  126. 126.
    Garnaas KR, Windebank AJ, Blexrud MD, Kurtz SB: Ultrastructural changes produced in dorsal root ganglia in vitro by exposure to ethtylene oxide from hemo-dialysis. J Neuropathol Exp Neurol 50: 256, 1991PubMedGoogle Scholar
  127. 127.
    Ansorge W, Pelger M, Dietrich W, Baurmeister U: Ethylene oxide in dialyzer rinsing fluid: effect of rinsing technique, dialyzer storage time, and potting compound. Artif Organs 11: 118, 1987PubMedCrossRefGoogle Scholar
  128. 128.
    Ing TS, Daugirdas JT: Extractable ethylene oxide from cuprammonium cellulose plate dialyzers. Trans Am Soc Artif Intern Organs 21: 108, 1986Google Scholar
  129. 129.
    Wass U, Belin L, Delin K: Longitudinal study of specific IgE and IgG antibodies in a patient sensitized to ethylene oxide through dialysis. J Allergy Clin Immunol 82: 679, 1988PubMedGoogle Scholar
  130. 130.
    Grammer LC, Paterson BF, Roxe D et al.: IgE against ethylene oxide-altered human serum albumin in patients with anaphylactic reactions to dialysis. J Allergy Clin Immunol 76: 511, 1985PubMedGoogle Scholar
  131. 131.
    Grammer LC, Patterson R: IgE against ethylene oxide-altered human serum albumin (ETO-HSA) as an etiologic agent in allergic reactions of hemodialysis patients. Artif Organs 11: 97, 1987PubMedGoogle Scholar
  132. 132.
    Grammer LC, Roberts M, Wiggins CA, Fitzsimmons RR, Ivanovich PT, Roxe DM, Patterson R: A comparison of cutaneous testing and ELIS A testing for assessing reactivity to ethylene oxide-human serum albumin in hemodialysis patients with anaphylactic reactions. J Allergy Clin Immunol 87: 674, 1991PubMedGoogle Scholar
  133. 133.
    Marshall CP, Pearson FC, Sagona MA, Lee W, Wathen RL, Ward RA, Dolovich J: Reactions during hemodialysis caused by allergy to ethylene oxide gas sterilization. J Allergy Clin Immunol 75: 563, 1985PubMedGoogle Scholar
  134. 134.
    Bousquet J, Maurice F, Rivory JP, Skassa-Brociek W, Florence P, Chouzenoux R, Mion C, Michel FB: Allergy in long-term hemodialysis. II. Allergic and atopic patterns of a population of patients undergoing long-term hemodialysis. J Allergy Clin Immunol 81: 605, 1988PubMedGoogle Scholar
  135. 135.
    Daugirdas JT, Potempa LD, Dinh N, Gandhi VC, Ivanovich PJ, Ing TS: Plate, coil, and hollow-fiber cuprammonium cellulose dialyzers: discrepancy between incidence of anaphylactic reactions and degree of complement activation. Artif Organs 11: 140, 1987PubMedCrossRefGoogle Scholar
  136. 136.
    Maurice F, Rivory JP, Larsson PH, Johansson SG, Bousquet J: Anaphylactic shock caused by formaldehyde in a patient undergoing long-term hemodialysis. J Allergy Clin Immunol 77: 594, 1986PubMedGoogle Scholar
  137. 137.
    Kessler M, Cao HT, Mariot A, Chanliau J: Hemodialysis-associated complications due to sterilizing agents ethylene oxide and formaldehyde. Contrib Nephrol 62: 13, 1988PubMedGoogle Scholar
  138. 138.
    Wenzel SK, Sharma AM, Keller F: Repeated dialysis anaphylaxia. Nephrol Dial Transplant 5: 821, 1990Google Scholar
  139. 139.
    Rault R, Silver MS: Severe reactions during hemodialysis. Am J Kidney Dis 5: 128, 1985PubMedGoogle Scholar
  140. 140. Update: Acute allergic reactions associated with reprocessed hemodialyzers — United States, 1989–90. MMWR 40: 147, 153, 1991Google Scholar
  141. 141.
    Pegues DA, Consuelo M, Beck-Sague, Woollen SW, Greenspan B, Burns SM, Bland LA, Arduino MJ, Favero MS, Mackow RC, Jarvis WR: Anaphylactoid reactions associated with reuse of hollow fiber hemodialyzers and ACE inhibitors. Kidney Int 42: 1232, 1992PubMedGoogle Scholar
  142. 142.
    Parnes EL, Shapiro WB: Anaphylactoid reactions in hemodialysis patients treated with the AN69 dialyzer. Kidney Int 40: 1148, 1991PubMedGoogle Scholar
  143. 143.
    Schulman G, Hakim R, Arias R, Silverberg M, Kaplan AP, Arbeit L: Bradykinin generation by dialysis membranes: possible role in anaphylactic reaction. Am Soc Nephrol 3: 1563, 1993Google Scholar
  144. 144.
    Vaziri ND: Is contact activation of the coagulation system involved in the genesis of the first-use syndrome. Artif Organs 11: 163, 1987PubMedGoogle Scholar
  145. 145.
    Chargin K: Skin disease in non-surgical renal disease. Arch Dermatol Syphilol 26: 314, 1932Google Scholar
  146. 146.
    Balaskas EV, Chu M, Uldall RP, Gupta A, Oreopoulos DG: Pruritus in continuous ambulatory peritoneal dialysis and hemodialysis patients. Pent Dial Int 13: S527, 1993Google Scholar
  147. 147.
    Mettang T, Fritz P, Weber J, Machleidt C, Hubel E, Kuhlmann U: Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol 34: 136, 1990PubMedGoogle Scholar
  148. 148.
    Stahle-Backdahl M: Uremic pruritus. Clinical and experimental studies. Acta Derm Venereol 145(Suppl): 1, 1989Google Scholar
  149. 149.
    Stahle-Backdaht M., Wahlgren CF, Hagermark O: Computerized recording of itch in patients on maintenance hemodialysis. Acta Derm Venereol 69: 410, 1989Google Scholar
  150. 150.
    Gilchrest BA, Stern RS, Steinman TI, Brown RS, Arndt KA, Anderson WW: Clinical features of pruritus among patients undergoing maintenance hemodialysis. Arch Dermatol 118: 154, 1982PubMedGoogle Scholar
  151. 151.
    Lempert KD, Baltz PS, Welton WA, Whittier FC: Pseudouremic pruritus: a scabies epidemic in a dialysis unit. Am J Kidney Dis 5: 117, 1985PubMedGoogle Scholar
  152. 152.
    Pascual J, Medina S, Teruel JL, Freire P, Ortuno J: Captopril-induced lichenoid eruption in an uremic patient. (Letter) Nephron 56: 110, 1990PubMedGoogle Scholar
  153. 153.
    Stahle-Backdahl M: Stratum corneum hydration in patients undergoing maintenance hemodialysis. Acta Derm Venereol 68: 531, 1988PubMedGoogle Scholar
  154. 154.
    Grosshans E, Maleville J, Jahn H, Frankhauser J: Pruritus during repeated hemodialysis in chronic renal insufficiency. Etiological and histopathological data. Bulletin de la Société franÇaise de Dermatologie et de Syphiligraphie 77: 828, 1970PubMedGoogle Scholar
  155. 155.
    Massry SG, Kleeman CR: Calcium metabolism in patients treated with maintenance haemodialysis. Triangle 10: 147, 1971PubMedGoogle Scholar
  156. 156.
    Parfitt AM, Massry SG, Winfield AC, DePalma JR, Gordon A: Disordered calcium and phosphorus metabolism during maintenance hemodialysis. Correlation of clinical, roentgenographic and biochemical changes. Am J Med 51: 319, 1971PubMedGoogle Scholar
  157. 157.
    Stockenhuber F, Kurz RW, Sertl K, Grimm G, Balcke P: Increased plasma histamine levels in uraemic pruritus. Clin Sci 79: 477, 1990PubMedGoogle Scholar
  158. 158.
    Francos GC, Kauh YC, Gittlen SD, Schulman ES, Besarab A, Guyal S, Burke JF Jr: Elevated plasma histamine in chronic uremia. Effects of ketotifen on pruritus. Ira J Dermatol 30: 884, 1991Google Scholar
  159. 159.
    Dimkovic N, Djukanovic L, Radmilovic A, Bojic P, Juloski T: Uremic pruritus and skin mast cells. Nephron 61: 5, 1992PubMedGoogle Scholar
  160. 160.
    Matsumoto M, Ichimaru K, Horie A: Pruritus and mast cell proliferation of the skin in end stage renal failure. Clin Nephrol 23: 285, 1985PubMedGoogle Scholar
  161. 161.
    Cohen EP, Russell TJ, Garancis JC: Mast cells and calcium in severe uremic itching. Am J Med Sci 303: 360, 1992PubMedGoogle Scholar
  162. 162.
    Masi CM, Cohen EP: Dialysis efficacy and itching in renal failure. Nephron 62: 257, 1992PubMedGoogle Scholar
  163. 163.
    Tan JK, Haberman HF, Coldman AJ: Identifying effective treatments for uremic pruritus. J Am Acad Dermatol 25: 811, 1991PubMedGoogle Scholar
  164. 164.
    Breneman DL, Cardone JS, Blumsack RF, Lather RM, Searle EA, Pollack VE: Topical capsaicin for treatment of hemo-dialysis-related pruritus. J Am Acad Dermatol 26: 91, 1992PubMedGoogle Scholar
  165. 165.
    De Marchi S, Cecchin E, Villalta D, Sepiacci G, Santini G, Bartoli E: Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia [see comments]. N Engl J Med 326: 969, 1992PubMedCrossRefGoogle Scholar
  166. 166.
    Schaefer RM, Rauterberg EW, Deppisch R, Vienken J: Assembly of terminal SC5b-9 complement complexes: a new index of blood-membrane interaction. Miner Electrolyte Metab 16: 73, 1990PubMedGoogle Scholar
  167. 167.
    Brunner J, Seidel D: Comparative hemolysis studies of various dialysis technics. Z Urol Nephrol 78: 381, 1985PubMedGoogle Scholar
  168. 168.
    Blumberg A: Pathogenesis of anemia due to kidney disease. Nephron 1: 15, 1989CrossRefGoogle Scholar
  169. 169.
    Taccone GM, Lubrano R, Belli A, Meloni C, Morosetti M, Meschini L, Elli M, Boffo V, Pisani F, Giardini O: Disappearance of oxidative damage to red blood cell membranes in uremic patients following renal transplant. Trans Am Soc Artif Intern Organs 35: 533, 1989Google Scholar
  170. 170.
    Durak I, Akyol O, Basesme E, Canbolat O, Kayutcu M: Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron 66: 76, 1994PubMedGoogle Scholar
  171. 171.
    Lubrano R, Taccone GM, Mazzarella V, Bandino D, Citti G, Elli M, Gardino O, Casciani C: Relationship between red blood cell lipidperoxidation, plasma hemoglobin, and red blood cell osmotic resistance before and after vitamin E supplementation in hemodialysis patients. Artif Organs 10: 245, 1986PubMedGoogle Scholar
  172. 172.
    Peuchant E, Salles C, Vallot C, Wone C, Jensen R: Increase of erythrocyte resistance to hemolysis and modification of membrane lipids induced by hemodialysis. Clin Chim Acta 178: 271, 1988PubMedGoogle Scholar
  173. 173.
    Zachee P, Ferrant A, Daelemans R, Coolen L, Goosens W, Lins RL, Couttenye M, DeBroe ME, Boogaerts MA: Oxidative injury to erythrocytes, cell reigiity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment. Nephron 65: 288, 1993PubMedGoogle Scholar
  174. 174.
    Gault MH, Duffett S, Purchase L, Murphy J: Hemodialysis intravascular hemolysis and kinked blood lines. Nephron 62: 267, 1992PubMedGoogle Scholar
  175. 175.
    Gordon SM, Bland LA, Alexander SR, Newman HF, Arduino MJ, Jarvis WR: Hemolysis associated with hydrogen peroxide at a pediatric dialysis center. Am J Nephrol 10: 123, 1990PubMedGoogle Scholar
  176. 176.
    Ng YY, Chow MP, Lyou JY, Huh Y, Yung CH, Fan CD, Huang TP: Resistance to erythropoietin: immunohemolytic anemia induced by residual formaldehyde in dialyzers. Am J Kidney Dis 21: 213, 1993PubMedGoogle Scholar
  177. 177.
    Klein E: Effects of disinfectants in renal dialysis patients. Environ Health Perspect 69: 45, 1986PubMedGoogle Scholar
  178. 178.
    Hudson S, Taylor JE, Stewart WK: Undetected excessive ultrafiltration and serious haemolysis during maintenance haemodialysis. Nephrol Dial Transplant 8: 477, 1993PubMedGoogle Scholar
  179. 179.
    Ebel H, Saure B, Laage C, Dittmar A, Keuchar M, Stell-waag M, Lange H: Influence of computer-modulated profile haemodialysis on cardiac arrhythmias. Nephrol Dial Transplant 1: 165, 1990Google Scholar
  180. 180.
    Kinoshita O, Kamakura S, Kimura G, Omae T: Increased ventricular vulnerability during haemodialysis. (Letter) Lancet 338: 1333, 1991PubMedGoogle Scholar
  181. 181.
    Rombola G, Colussi G, De FM, Frontini A, Minetti L: Cardiac arrhythmias and electrolyte changes during haemodialysis. Nephrol Dial Transplant 7: 318, 1992PubMedGoogle Scholar
  182. 182.
    Saragoca MA, Canziani ME, Cassiolato JL, Gil MA, Andrade JL, Draibe SA, Martinez EE: Left ventricular hypertrophy a risk factor for arrhythmias in hemodialysis patients. J Cardiol Pharma 17(Suppl 2): S136, 1991Google Scholar
  183. 183.
    Sforzini S, Latini R, Mingardi G, Vincenti A, Redaelli B: Ventricular arrhythmias and four-year mortality in haemodialysis patients. Gruppo Emodialisi e Patologie Cardiovascolari [see comments]. Lancet 339: 212, 1992PubMedGoogle Scholar
  184. 184.
    Shapira OM, Bar KY: ECG changes and cardiac arrhythmias in chronic renal failure patients on hemodialysis. J Electrocardiol 25: 273, 1992PubMedGoogle Scholar
  185. 185.
    Krivoshiev S, Antonov S, Koteva A, Kirijakov Z: Paroxysmal atrial fibrillation during haemodialysis. (Letter) Nephrol Dial Transplant 5: 474, 1990PubMedGoogle Scholar
  186. 186.
    Fantuzzi S, Caico S, Amatruda O, Cervini P, Abu-Turky H, Baratelli L, Donati D, Gastaldi L: Hemo-dialysis-associated cardiac arrhythmias: a lower risk with bicarbonate? Nephron 58: 196, 1991PubMedGoogle Scholar
  187. 187.
    Ritz E, Rambausek M, Mall G: Cardiac changes in uremia and the possible relation to cardiovascular instability on dialysis. Contrib Nephroll 78: 221, 1990Google Scholar
  188. 188.
    Rostand SG, Rutsky EA: Pericarditis in end-stage renal disease. (Review) Cardiol Clin 8: 701, 1990PubMedGoogle Scholar
  189. 189.
    Nishimura M, Nakanishi T, Yasui A, Tsuji Y, Kunishige H, Hirabayashi M, Takahashi H, Yoshimura M: Serum calcium increases the incidence of arrhythmias during acetate hemodialysis. Am J Kidney Dis 19: 149, 1992PubMedGoogle Scholar
  190. 190.
    Gawaz M, Mujais SK: Platelet membrane glycoprotein abnormalities and uremic bleeding. J Nephrol 1995. In pressGoogle Scholar
  191. 191.
    Gawaz MP, Dobos G, Mujais SK: Impaired function of platelet glycoprotein GPllb/llla in end stage renal disease. Am Soc Nephrol 5: 36, 1994Google Scholar
  192. 192.
    Maggiore Q, Pizzarelli F, Zoccali C, Sisca S, Nocolo F, Parlongo S: Effect of extracorporeal blood cooling on dialytic arterial hypotension. Proc Eur Dial Transplant Assoc 18:587, 1981Google Scholar
  193. 193.
    Ganong WF: Review of Medical Physiology, 15th Ed. Norwalk, Connecticut, Appleton E Lange, 1991, p 234Google Scholar
  194. 194.
    Harrison P, Jansson K, Kronenberg H, Mahony J, Tiller D: Cold agglutinin formation in patients undergoing haemodialysis. A possible relationship to dialyser re-use. Aust NZ J Med 5: 195, 1975Google Scholar
  195. 195.
    Fortner R, Nowakowski A, Carter C, King L, Knepshield J: Death due to overheated dialysate during dialysis. Ann Intern Med 73: 443, 1970PubMedGoogle Scholar
  196. 196.
    Berkes S, Kahn S, Chazan J, Garella S: Prolonged hemolysis from overheated dialysate. Ann Intern Med 83: 363, 1975PubMedGoogle Scholar
  197. 197.
    Ham T, Shen S, Fleming E, Castle WB: Studies on the destruction of red blood cells. IV. Blood 3: 373, 1948PubMedGoogle Scholar
  198. 198.
    Mennim P, Coyle CF, Taylor J: Venous air embolism associated with removal of central venous catheter. Br Med J 305: 171, 1992Google Scholar
  199. 199.
    Halliday P, Anderson DN, Davidson AI, Page JG: Management of cerebral air embolism secondary to a disconnected central venous catheter. Br J Surg 81, 1994Google Scholar
  200. 200.
    Phifer TJ, Bridges M, Conrad SA: The residual central venous catheter trace-an occult source of lethal air embolism: case report. J Trauma 31: 1558, 1991PubMedGoogle Scholar
  201. 201.
    Aibiki M, Ogura S, Seki K, Honda K, Omegaki O, Shirakawa Y, Ogli K: Role of vagal afferents in hypotension induced by venous air embolism. Am J Physiol 266: R790, 1994PubMedGoogle Scholar
  202. 202.
    Ohno S, Suzuki N, Kitamura S: The roles of platelet-activating factor (PAF) in pulmonary vasoconstriction during venous air embolism in anesthetized mongrel dogs. J Lipid Mediat 5: 187, 1992PubMedGoogle Scholar
  203. 203.
    Lam KK, Hutchinson RC, Gin T: Severe pulmonary edema after venous air embolism (Review) Can J Anaesth 40: 964, 1993PubMedGoogle Scholar
  204. 204.
    Wang D, Li MH, Hsu K, Shen CY, Chen HI, Lin YC Air embolism-induced lung injury in isolated rat lungs.. J Appl Physiol 72: 1235, 1992PubMedGoogle Scholar
  205. 205.
    Bergh K, Hjelde A, Iversen OJ, Brubakk AO: Variability over time of complement activation induced by air bubbles in human and rabbit sera. J Appl Physiol 74: 1811, 1993PubMedGoogle Scholar
  206. 206.
    Thorsen T, Klausen H, Lie RT, Holmsen H: Bubble-induced aggregation of platelets: effects of gas species, proteins, and decompression. Undersea Hyperbar Med 20: 101, 1993Google Scholar
  207. 207.
    Brenton BC, Mittelstaedt CA, Curnes JT, Scatliff JH: Real-time ultrasonographic visualization of intra-cranial air embolism. J Ultrasound Med 1: 379, 1982PubMedGoogle Scholar
  208. 208.
    Bunegin L, Wahl D, Albin MS: Detection and volume estimation of embolic air in the middle cerebral artery using transcranial Doppler sonography. Stroke 25: 595, 1994Google Scholar
  209. 209.
    Markus H: Transcranial Doppler detection of circulating cerebral emboli. A review. (Review) Stroke 24: 1246, 1993PubMedGoogle Scholar
  210. 210.
    Artru AA: Modification of a new catheter for air retrieval and resuscitation from lethal venous air embolism: effect of nitrous oxide on air retrieval. Anesth Analg 75: 226, 1992PubMedGoogle Scholar
  211. 211.
    Hanna PG, Gravensein N, Pashayan AG: In vitro comparison of central venous catheters for aspiration of venous air embolism: effect of catheter type, catheter tip position, and cardiac inclination [see comments]. J Clin Anesth 3: 290, 1991PubMedGoogle Scholar
  212. 212.
    Dudney TM, Elliott CG: Pulmonary embolism from amniotic fluid, fat, and air. Prog Cardiovasc Dis 36: 447, 1994PubMedGoogle Scholar
  213. 213.
    Orebaugh SL: Venous air embolism: clinical and experimental considerations. Crit Care Med 20: 1169, 1992PubMedGoogle Scholar
  214. 214.
    Weiss LD, Van MK: The applications of hyperbaric oxygen therapy in emergency medicine [see comments]. (Review) Am J Emerg Med 10: 558, 1992PubMedGoogle Scholar
  215. 215.
    Dunbar EM, Fox R, Watson B, Akrill P: Successful late treatment of venous air embolism with hyperbaric oxygen. Postgrad Med J 66: 469, 1990PubMedCrossRefGoogle Scholar
  216. 216.
    Annane D, Troche G, Delisle F, Devauchelle P, Paraire F, Raphael JC, Gajdos P: Effects of mechanical ventilation with normobaric oxygen therapy on the rate of air removal from cerebral arteries. Crit Care Med 22: 851, 1994PubMedGoogle Scholar
  217. 217.
    Mongan P, Peterson RE, Culling RD: Pressure monitoring can accurately position catheter for air embolism aspiration. J Clin Monit 8: 121, 1992PubMedGoogle Scholar
  218. 218.
    Schwarzbeck A, Wagner L, Squarr HU, Strauch M: Clotting in dialyzers due to low pH of dialysis fluid. Clin Nephrol 7: 125, 1977PubMedGoogle Scholar
  219. 219.
    Renfrew R, Buselmeier TJ, Kjellstrand CM: Pericarditis and renal failure. Ann Rev Med 31: 345, 1980PubMedGoogle Scholar
  220. 220.
    Osanloo E, Salhoub RJ, Cioffi RF, Parker RH: Viral pericarditis in patients receiving hemodialysis. Arch Intern 9: 301, 1979Google Scholar
  221. 221.
    Comty CM, Shapiro FL: Cardiac complications of regular dialysis treatment, in Replacement of Renal Function, edited by Drukker W, Parsons FM, Maher JF, The Hague, Martinus Nijhoff Medical Division, 1978, p 519Google Scholar
  222. 222.
    Cooper FW Jr, Stead EA, Warren JV: The beneficial effect of intravenous infusions in acute pericardial tamponade. Ann Surg 120: 822, 1944PubMedCrossRefGoogle Scholar
  223. 223.
    Watson AJJ, Finn MMR, Keaugh JAB: Cardiac tamponade without demonstrable pulsus paradoxus in hemodialysis patients. Irish J Med Sci 150: 78, 1981PubMedGoogle Scholar
  224. 224.
    Horton JD, Gelfand MC, Sherber HS: Natural history of asymptomatic pericardial effusions in patients on maintenance hemodialysis. Proc Dial Transplant Forum 7: 76, 1977Google Scholar
  225. 225.
    Zabaneh RI, Ejaz AA, Khan AA, Nawab ZM, Leehey DJ, Ing TS: Use of a phosphorus-enriched dialysis solution to hemodialyze a patient with lithium intoxication. Artif Organs 19: 94, 1995PubMedGoogle Scholar
  226. 226.
    Leehey DJ, Daugirdas JT, Ing TS: Early drainage of pericardial effusion in patients with dialysis pericarditis. Arch Intern Med 143: 1673, 1983PubMedGoogle Scholar
  227. 227.
    Buselmeier TJ, Simmons RL, Najarian JS, von Hartitzch B, Dietzman RH, Kjellstrand CM: Intractable uremic pericardial effusion. Proc Eur Dial Transplant Assoc 10: 289, 1973PubMedGoogle Scholar
  228. 228.
    Daugirdas JT, Leehey DK, Popli S, McCray GM, Gandhi VC, Pifarre R, Ing TS: Subxiphoid pericardiotomy for hemodialysis-associated pericardial effusion. Arch Intern Med 146: 1113, 1986PubMedGoogle Scholar
  229. 229.
    Ghavamian M, Gutch CF, Hughes RK, Kopp KF, Kolff WJ: Pericardial tamponade in chronic-hemodialysis patients: Treatment by pericardiectomy. Arch Intern Med 131:249, 1973PubMedGoogle Scholar
  230. 230.
    Kennedy AC, Linton AL, Eaton JC: Urea levels in cerebrospinal fluid after haemodialysis. Lancet 1962, 1: 410PubMedGoogle Scholar
  231. 231.
    Peterson H de C, Swanson AG: Acute encephalopathy occurring during hemodialysis — the reverse urea effect. Arch Intern Med 113: 877, 1964PubMedGoogle Scholar
  232. 232.
    Kleeman CR: Metabolic coma. Kidney Int 36: 1142, 1989PubMedGoogle Scholar
  233. 233.
    Kennedy AC, Linton AL, Luke RG, Renfrew S: Electroencephalographic changes during haemodialysis. Lancet 1: 408, 1963PubMedGoogle Scholar
  234. 234.
    Rosen SM, O’Connor K, Shaldon S: Haemodialysis disequilibrium. Br Med J 2: 672, 1964PubMedGoogle Scholar
  235. 235.
    Scribner BH: Trans Am Soc Artif Intern Organs 8: 195, 1962Google Scholar
  236. 236.
    Kerr DNS, Edwards EC: Discussion in acute renal failure, edited by Shaldon S, Cook GC, Oxford, Blackwell Scientific Publications, 1964, p 78Google Scholar
  237. 237.
    Sitprija V, Holmes JH: Preliminary observations on the change in intracranial pressure and intraocular pressure during hemodialysis. Trans Am Soc Artif Intern Organs 8: 300, 1962PubMedGoogle Scholar
  238. 238.
    Port FK, Johnson WJ, Klass DW: Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int 3: 327, 1973PubMedGoogle Scholar
  239. 239.
    Silver SM, DeSimone JA Jr, Smith DA, Sterns RH: Dialysis disequilibrium syndrome (DDS) in the rat: role of the ‘reverse urea effect’. Kidney Int 42: 161, 1992PubMedGoogle Scholar
  240. 240.
    Arieff AI, Guisado R, Massry SG, Lazarowitz VC: Central nervous system pH in uremia and the effects of hemodialysis. J Clin Invest 58: 306, 1976PubMedGoogle Scholar
  241. 241.
    Kennedy AC, Linton AL, Luke RG, Renfrew S, Dinwoodie A: The pathogenesis and prevention of cerebral dysfunction during dialysis. Lancet 1: 790, 1964PubMedGoogle Scholar
  242. 242.
    Rodrigo F, Shideman J, McHugh R, Buselmeier T, Kjellstrand C: Osmolality changes during hemodialysis. Ann Intern Med 86: 554, 1977PubMedGoogle Scholar
  243. 243.
    Kelleher SP, Schulman G: Severe metabolic alkalosis complicating regional citrate hemodialysis. Am J Kidney Dis 9: 235, 1987PubMedGoogle Scholar
  244. 244.
    Silverstein FJ, Oster JR, Perez GO, Materson BJ, Lopez RA, Al-Reshaid K: Metabolic alkalosis induced by regional citrate hemodialysis. Trans Am Soc Artif Intern Organs 35: 22, 1989Google Scholar
  245. 245.
    van der Meulen J, Janssen MJ, Langendijk PN, Bouman AA, Oe PI: Citrate anticoagulation and dialyfeate with reduced buffer content in chronic hemodialysis. Clin Nephrol 37: 36, 1992PubMedGoogle Scholar
  246. 246.
    Brueggemeyer CD, Ramirez G: Dialysate concentrate: a potential source for lethal complications. Nephron 46: 397, 1987PubMedCrossRefGoogle Scholar
  247. 247.
    Hartmann A, Reisaeter A, Holdaas H, Rolfsen B, Fauchald P: Accidental metabolic acidosijs during hemodialysis. Artif Organs 18: 214, 1994PubMedGoogle Scholar
  248. 248.
    Said R, Quintanilla A, Levin N, Ivanovich P: Acute hemolysis due to profound hypo-osmalality. A complication of hemodialysis. J Dial 1: 447, 1977PubMedGoogle Scholar
  249. 249.
    Brezis M, Brown RS: An unsuspected cause for metabolic acidosis in chronic renal failure: sorbent system hemodialysis. Am J Kidney Dis 6: 425, 1985PubMedGoogle Scholar
  250. 250.
    Wathen RL, Burcham CW Jr: Understanding the dangers of fluoride during dialysis. Nephrol News Issues (Sept): 32, 1993Google Scholar
  251. 251.
    Klein WJ Jr, Metz EN, Price AR: Acute copper intoxication. A hazard of hemodialysis. Arch Intern Med 129: 578, 1972PubMedGoogle Scholar
  252. 252.
    Schuett H, Port FK: Hemolysis in hemodialysis patients. Dial Transplant 9: 345, 1980Google Scholar
  253. 253.
    Stema RH, Ocdol H, Schrier RW, Narins RG: Hyponatremia: pathophysiology, diagnosis, and therapy, in Clinical Disorders of Fluid and Electrolyte Metabolism. 5th Ed, edited by Narins RG, New York. McGraw-Hill Inc. 1994, p 585Google Scholar
  254. 254.
    Bluemle LW Jr: Current status of chronic hemodialysis. Am J Med 44: 749, 1968PubMedGoogle Scholar
  255. 255.
    Nickey WA, Chinitz VL, Kim KE, Onesti G, Swartz C: Hypernatremia from water softener malfunction during home dialysis. JAMA 214: 915, 1970PubMedGoogle Scholar
  256. 256.
    Lindner A, Moskovtchenko JF, Traeger J: Accidental mass hypernatremia during hemodialysis. Nephron 9: 99, 1972PubMedGoogle Scholar
  257. 257.
    Lazarus JM: Complications in hemodialysis: an overview. Kidney Int 18: 783, 1980Google Scholar
  258. 258.
    Morrison G, Michelson EL, Brown S, Morganroth J: Mechanism of prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int 17: 811, 1980PubMedGoogle Scholar
  259. 259.
    Seldin DW, Carter NW, Rector FC Jr: Consequences of renal failure and their management, in Diseases of the Kidney, 2nd Ed, edited by Strauss MB, Welt LG, Boston, Little, Brown and Company, Boston, 1971, p 211Google Scholar
  260. 260.
    Wiegand C, Davin T, Raij L, Kjellstranfl C: Life-threatening hypokalemia during hemodialysii. Trans Am Soc Artif Intern Organs 25: 416, 1975Google Scholar
  261. 261.
    Wiegand CF, Davin TD, Raij L, Kjellstrand CM: Severe hypokalemia induced by hemodialysis. Arch Intern Med 141: 167, 1981PubMedGoogle Scholar
  262. 262.
    Blumberg A, Weidmann P, Ferrari P: Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int 41: 369, 1992PubMedGoogle Scholar
  263. 263.
    Kjellstrand CM, Eaton JW, Yawata Y, Swofford H, Kolpin CF, Buselmeier TJ, von Hartitzsch B, Jacob HS: Hemolysis in dialysed patients caused by chloramines. Nephron 13: 247, 1974Google Scholar
  264. 264.
    Orringer EP, Mattern WD: Formaldehyde-induced hemolysis during chronic hemodialysis. N Engl J Med 294: 1416, 1976PubMedCrossRefGoogle Scholar
  265. 265.
    Carlson DJ, Shapiro FL: Methemoglobinemia from well water nitrates: a complication of home dialysis. Ann Intern Med 73: 757, 1970PubMedGoogle Scholar
  266. 266.
    Hoy RH: Accidental systemic exposure to sodium hypochlorite (Clorox) during hemodialysis. Am J Hosp Pharm 38: 1512, 1981PubMedGoogle Scholar
  267. 267.
    McIvor M, Baltazar RF, Beitran J, Mower MM, Wend R, Lustgarten J, Salomon J: Hyperkalemia and cardiac arrest from fluoride exposure during hemodialysis. Am J Cardiol 51: 901, 1983PubMedGoogle Scholar
  268. 268.
    Winchester JF, Gelfand MC, Knepshield JH, Schreiner GE: Dialysis and hemoperfusion of poisons and drugs — update. Trans Am Soc Artif Intern Organs 23: 762, 1977PubMedGoogle Scholar
  269. 269.
    Popovtzer MM, Knochel JP, Kumar R: Disorders of calcium, phosphorus, vitamin D, and parathyroid hormone activity, in Renal and Electrolyte Disorders, 4th Ed, edited by Schrier RW, Boston, Little, Brown and Company, 1992, p 287Google Scholar
  270. 270.
    Lentz RD, Brown DM, Kjellstrand CM: Treatment of severe hypophosphatemia. Ann Intern Med 89: 941, 1978PubMedGoogle Scholar
  271. 271.
    Tamm HS, Nolph KD, Maher JF: Factors affecting plasma calcium concentration during hemodialysis. Arch Intern Med 128: 769, 1971PubMedGoogle Scholar
  272. 272.
    Carney SL, Gillies AHB: Acute dialysis hypercalcemia and dialysis phosphate loss. Am J Kidney Dis 11: 377, 1988PubMedGoogle Scholar
  273. 273.
    Argiles A, Kerr PG, Canaud B, Flavier JL, Mion C: Calcium kinetics and the long-term effects of lowering dialysate calcium concentration. Kidney Int 43: 630, 1993PubMedGoogle Scholar
  274. 274.
    Ott SM, Maloney NA, Coburn JW, Alfrey AC, Sherrard DJ: The prevalence of bone aluminum deposition in renal osteody strophy and its relation to the response to calcitriol therapy. N Engl J Med 307: 709, 1982PubMedCrossRefGoogle Scholar
  275. 275.
    Davenport A, Goel S, Mackenzie JC: Treatment of hypercalcaemia with pamidronate in patients with end-stage renal failure. Scand J Urol Nephrol 27: 447, 1993PubMedCrossRefGoogle Scholar
  276. 276.
    Rivera-Vasquez AB, Noriega-Sanchez A, Ramirez-Gonzales R, Martinez-Maldonado M: Acute hypercalcemia in hemodialysis patients: distinction from ‘dialysis dementia’. Nephron 25: 243, 1980Google Scholar
  277. 277.
    Freeman RM, Lawton RL, Chamberlain MA: Hard-water syndrome. N Engl J Med 276: 113, 1967CrossRefGoogle Scholar
  278. 278.
    Drukker W: The hard water syndrome: a potential hazard during regular dialysis treatment. Proc Eur Dial Transplant Assoc 5: 284, 1968Google Scholar
  279. 279.
    Evans DB, Slapak M: Pancreatitis in the hard water syndrome. Br Med J 5: 284, 1968Google Scholar
  280. 280.
    Mulloy AL, Mulloy LL, Weinstein RS: Hypercalcemia due to hard water used for home dialysis. South Med J 85: 1131, 1992PubMedGoogle Scholar
  281. 281.
    Tzamaloukas AH: Hypercalcemia due to hard well water in a home hemodialysis patient. South Med J 86: 844, 1993PubMedGoogle Scholar
  282. 282.
    Govan JR, Porter CA, Cook JGH, Dixon B, Trafford JAP: Acute magnesium poisoning as a complication of chronic intermittent haemodialysis. Brit Med J 2: 278, 1968PubMedGoogle Scholar
  283. 283.
    Taves DR, Freeman RB, Kamm DE, Ramos CP, Scribner BH: Hemodialysis with fluoridated dialysate. Trans Am Soc Artif Intern Organs 14: 412, 1968PubMedGoogle Scholar
  284. 284.
    Johnson WJ, Taves DR: Exposure to excessive fluoride during hemodialysis. Kidney Int 5: 451, 1974PubMedGoogle Scholar
  285. 285.
    Keshaviah PR et al.: Investigation of the Risks and Hazards Associated with Hemodialysis Devices, Technical Report, Rockville, Maryland, U.S. Food and Drug Administration, Department of Health, Education and Welfare, 1980Google Scholar
  286. 286.
    Keshaviah PR: Pretreatment and preparation of city worker for hemodialysis, in: Replacement of renal function by dialysis, 3rd Ed, edited by Maher JF, Dordrecht, Kluwer Academic Publishers, 1989, p 189Google Scholar
  287. 287.
    Amow PM, Bland LA, Garcia-Houchins S, Fridkin S, Fellner SK: An outbreak of fatal fluoride intoxication in a long-term hemodialysis unit. Ann Intern Med 131: 339, 1994Google Scholar
  288. 288.
    Clifford DA: Ion exchange and inorganic adsorption, in Water Quality and Treatment: A Handbook of Community Water Supplies, edited by Pontius FW, New York, McGraw-Hill, 1990, p 561Google Scholar
  289. 289.
    Anderson R, Beard JH, Sorley D: Fluoride intoxication in a dialysis unit-Maryland. MMWR Morb Mortal Wkly Rep 29: 134, 1980Google Scholar
  290. 290.
    Taves DR: Normal human serum fluoride concentrations. Nature 211: 192, 1966PubMedGoogle Scholar
  291. 291.
    Chaleil D, Sinon P, Tessier B, Cartier F, Allain P: Blood plasma fluoride in haemodialysed patients. Clin Chim Acta 156: 105, 1986PubMedGoogle Scholar
  292. 292.
    Berman L, Taves D, Mitra S, Newmark K: Inorganic fluoride poisoning: treatment by hemodialysis. N Engl J Med 189: 922, 1973Google Scholar
  293. 293.
    Wyngaarden JB, Smith LH JR, Bennett JC: Cecil Textbook of Medicine, 19th Ed, W.B. Saunders Co, Philadelphia, 1992, pp 862, 879Google Scholar
  294. 294.
    Carlson DJ, Shapiro FI: Methemoglobinemia from well water nitrates: a complication of home dialysis. Ann Intern Med 73: 757, 1970PubMedGoogle Scholar
  295. 295.
    Salvadori M, Martinelli F, Comparini L, Bandini S, Sodi A: Nitrate induced anaemia in home dialysis patients. Proc Eur Dial Transplant Assoc-Eur Renal Assoc 21: 321, 1984Google Scholar
  296. 296.
    Luehmann DA, Keshaviah PR, Ward RA, Klein E: A Manual on Water Treatment for Hemodialysis, US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Devices and Radiological Health, Sockville, Maryland, 1989, p 10Google Scholar
  297. 297.
    Jaffe ER, Heller P: Methemoglobinemia in man. Progr Hemat 4: 48, 1964Google Scholar
  298. 298.
    Tipple MA, Shusterman N, Bland LA, McCarthy MA, Favero MS, Arduino MJ, Reid MH, Jarvis WR: Illness in hemodialysis patients after exposure to chloramine contaminated dialysate. Trans Am Soc Artif Organs 37: 588, 1991Google Scholar
  299. 299.
    Meyer MA, Klein E: Granular activated carbon usage in chloramine removal from dialysis water. Artif Organs 7: 484, 1983PubMedGoogle Scholar
  300. 300.
    Symons J, Bellor T, Carswell J, Demarco J, Kropp K, Robeck G, Seeger D, Slocum C, Smith B, Stevens A: National organics reconnaissance survey for halogenated organics. J Am Water Works Assoc 7: 634, 1975Google Scholar
  301. 301.
    Bauer RC, Snoeyink VL: Reactions of chloramines with active carbon. J Water Pollut Control Fed 45: 2290, 1973Google Scholar
  302. 302.
    Caterson RJ, Savdie E, Raid E, Coutts D, Mahoney JF: Heinz-body haemolysis in haemodialyzed patients caused by chloramines in Sydney tap water. Med J Aust 2: 367, 1982PubMedGoogle Scholar
  303. 303. FDA safety alert: Chloramine contamination of hemodialysis water supplies. Am J Kidney Dis 11: 447, 1988Google Scholar
  304. 304.
    Eaton JW, Kolpin CF, Swofford HS, Kjellstrand CM, Jacob HS: Chlorinated urban water: a cause of dialysis-induced hemolytic anemia. Science 181: 463, 1973PubMedGoogle Scholar
  305. 305.
    Kjellstrand CM, Eaton JW, Yawata Y, Swofford H, Kolpin CF, Buselmeier TJ, von Hartitzsch B, Jacob HS: Hemolysis in dialized patients caused by chloramines. Nephron 13: 427, 1974PubMedGoogle Scholar
  306. 306.
    Favero MS, Petersen NJ, Carson LA, Bond WW, Hindman SH: Gram-negative water bacteria in hemodialysis systems. Health Lab Sci 12: 321, 1975PubMedGoogle Scholar
  307. 307.
    Comty C, Luehmann D, Wathen R, Shapiro F: Prescription water for chronic hemodialysis. Trans Am Soc Artif Intern Organs 20: 189, 1974Google Scholar
  308. 308.
    Ward DM, Minch K, Bahr TE: The use of ascorbic acid in water treatment for hemodialysis. Contemp Dial Nephrol 2: 33, 1985 and 3: 35, 1985Google Scholar
  309. 309.
    Neilan BA, Ehlers SM, Kolpin CF, Eaton JW: Prevention of chloramine-induced hemolysis in dialyzed patients. Clin Nephrol 10: 105, 1978PubMedGoogle Scholar
  310. 310.
    Gaynes R, Friedman C, Maclaven C, Foley K, Swartz R. Hemodialysis-associated febrile episodes: surveillance before and after major alteration in the water treatment system. Int J Artif Organs 13: 482, 1990PubMedGoogle Scholar
  311. 311.
    Goldman M, Vanherweghem JL: Bacterial infections in chronic hemodialysis patients: epidemiologic and pathophysiologic aspects. Adv Nephrol Necker Hosp 19: 315, 1990PubMedGoogle Scholar
  312. 312.
    Taniguchi T, Katsushima S, Lee K, Hidaka A, Konishi J, Ideguchi H, Kawaguchi Y: Endotoxemia in patients on hemodialysis. Nephron 56: 44, 1990PubMedGoogle Scholar
  313. 313.
    Vanholder R, Vanhaecke E, Ringoir S: Waterborne Pseudomonas septicemia. Trans Am Soc Artif Intern Organs 36, 1990Google Scholar
  314. 314.
    Gordon SM, Oettinger CW, Bland LA, Olivier JC, Ardvino WJ, Aquero SM, McAllister SK, Favero MS, Jarvis WR: Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin. Am Soc Nephrol 2: 1436, 1992Google Scholar
  315. 315.
    Alter MJ, Favero MS, Miller JK, Moyer LA, Bland LA: National surveillance of dialysis-associated diseases in the United States, 2987. Trans Am Soc Artif Intern Organs 35: 820, 1989Google Scholar
  316. 316.
    Alter MJ, Favero MS, Moyer LA, Miller JK, Bland LA: National surveillance of dialysis-associated diseases in the United States, 1988. Trans Am Soc Artif Intern Organs 36: 107, 1990Google Scholar
  317. 317.
    Alter MJ, Favero MS, Moyer LA, Bland LA: National surveillance of dialysis-associated diseases in the United States, 1989. Trans Am Soc Artif Intern Organs 37: 97, 1991Google Scholar
  318. 318.
    Flaherty JP, Garcia-Hutchins S, Chudy R, Arnow PM: An outbreak of gram-negative bacteremia traced to contaminated O-rings in reprocessed dialyzers. Ann Intern Med 119: 1072, 1993PubMedGoogle Scholar
  319. 319.
    Roberts B, Alvarado N, Garcia, Sous Y, Lopez O, Dukes C: Header sepsis syndrome: waterbome Xanthomonas-induced fevers. Dial Transplant 23: 464, 1994Google Scholar
  320. 320.
    Vanholder R, Vanhaecke E, Ringoir S: Pseudomonas septicemia due to deficient disinfectant mixing during reuse. Int J Artif Organs 15: 19, 1992PubMedGoogle Scholar
  321. 321.
    Bland L, Alter M, Favero M, Carson L, Cusick L: Hemodialyzer reuse: practices in the United States and implication for infection control. Trans Am Soc Artif Intern Organs 31: 556, 1985PubMedGoogle Scholar
  322. 322.
    Klinkmann H, Ebbighausen H, Uhlenbusch I, Vienken J: High-flux dialysis, dialysate quality and backtransport, in: Evolution in Dialysis Adequacy, Contributions in Nephrology, Vol 3, edited by Bonomini V, Basel, Karger, 1993, p 89Google Scholar
  323. 323.
    Bambauer R, Schauer M, Vienken J: Contamination of dialysis water and dialysate. Blood Purif 9: 32, 1991Google Scholar
  324. 324.
    Yamagami S, Adachi T, Sugirmura T, Wada S, Kishimoto T, Mackawa M, Yoshimura R, Niwa M, Terano Y, Shaldon S: Detection of endotoxin antibody in longterm dialysis patients. Int J Artif Organs 13: 205, 1990PubMedGoogle Scholar
  325. 325.
    Vanholder R, Van HE, Veys N, Ringoir S, Endotoxin transfer through dialysis membranes: small-versus large-pore membranes. Nephrol Dial Transplant 7: 333, 1992PubMedGoogle Scholar
  326. 326.
    Baz M, Durand C, Jaber K, Marzouk T, Berland Y: The impact of 12 years ultrapure dialysate use in hemodialysis related amyloidosis. Int J Artif Organs 547: 1990Google Scholar
  327. 327.
    Glenn CM, Astley SJ, Watkins SL: Dialysis-associated seizures in children and adolescents. Pediatr Nephrol 6: 182, 1992PubMedGoogle Scholar
  328. 328.
    Berman AT, Lorio R, Brelin J: Three central, acetabular fracture-dislocations secondary to metabolically induced seizures in ESRD patients. Orthopedics 16: 1265, 1993PubMedGoogle Scholar
  329. 329.
    Dahlberg PJ, Kisken WA, Newcomer KL, Yutuc WR, Mesenteric ischemia in chronic dialysis patients. Am J Nephrol 5: 327, 1985PubMedGoogle Scholar
  330. 330.
    Diamond SM, Emmett M, Henrich WL: Bowel infarction as a cause of death in dialysis patients. JAMA 256: 2545, 1986PubMedGoogle Scholar
  331. 331.
    Friedell ML: Cecal necrosis in the dialysis-dependent patient. Am Surgeon 51: 621, 1985PubMedGoogle Scholar
  332. 332.
    Leiba H, Oliver M, Shimshoni M, Bar-Khayum Y: Intraocular pressure fluctuations during regular hemodialysis and Ultrafiltration. Acta Ophthalmol 68: 320, 1990Google Scholar
  333. 333.
    Arora N, Lambrov FH Jr, Stewart MW, Vidrine-Parks L, Sandroni S: Sudden blindness associated with central nervous symptoms in a hemodialysis patient. Nephron 59: 490, 1991PubMedGoogle Scholar
  334. 334.
    Servilla KS, Groggel GC: Anterior ischemic optic neuropathy as a complication of hemodialysis. Am J Kidney Dis 8: 61, 1986PubMedGoogle Scholar
  335. 335.
    Quittenbaum S, Grefberg N: Massive bladder haemorrhage after thrombolytic therapy in a haemodialysis patient with secondary amyloidosis. Nephrol Dial Transplant 8: 1174, 1993PubMedGoogle Scholar
  336. 336.
    Matuszkiewicz RJ, Billip-Tomecka Z, Rowinski W, Sicinski A: Systemic streptokinase infusion for declotting of hemodialysis arteriovenous fistulas. Nephron 66: 67, 1994Google Scholar
  337. 337.
    Singhal PC, Lynn RI, Scharschmidt LA: Priaprism and dialysis. Am J Nephrol 6: 358, 1986PubMedGoogle Scholar
  338. 338.
    Wu SG, Lin SL, Shiao WY, Huang HW, Lin CF, Yang YH: Comparison of sublingual captopril, nifedipine and prazosin in hypertensive emergencies during hemo-dialysis. Nephron 65: 284, 1993PubMedGoogle Scholar
  339. 339.
    Gutierrez A, Bergstrom J, Alvestrand A: Hemodialysis associated protein catabolism with and without glucose in the dialysis fluid. Kidney Int 46: 814, 1994PubMedGoogle Scholar
  340. 340.
    Ikizler TA, Flakoll PJ, Parker RA, Hakim RM: Amino acid and albumin losses during hemodialysis. Kidney Int 46: 830, 1994PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Salim K. Mujais
    • 1
  • Todd Ing
    • 2
  • Carl Kjellstrand
    • 3
  1. 1.Section of NephrologyNorthwestern University School of MedicineChicagoUSA
  2. 2.Chicago Stritch School of MedicineLoyola UniversityMaywoodUSA
  3. 3.Department of MedicineUniversity of Alberta HospitalEdmontonCanada

Personalised recommendations